Wegovy maker Novo Nordisk warns of layoffs as competition grows | Business and Economy News
Novo Nordisk’s outgoing CEO, Lars Fruergaard Jorgensen, has warned that layoffs at the Danish pharmaceutical giant could be unavoidable as competition…
Tag: Novo
Trump Ramps Up Tariff Blitz, Novo Nordisk Profit Miss, More
Source: Bloomberg, 0:00 www.bloomberg.com #Trump #Ramps #Tariff #Blitz #Novo #Nordisk #Profit
Novo Nordisk (NVO) earnings Q2 2025
Boxes of Ozempic and Wegovy made by Novo Nordisk at a pharmacy in London on March 8, 2024. Hollie Adams…
Novo Nordisk is no longer a buy at UBS, which says compounding is here to stay
Novo Nordisk, the Danish maker of the wildly popular Ozempic and Wegovy drugs used for weight loss, was downgraded due…
Denmark’s Economy Runs on Novo. Will the Drugmaker’s Troubles Slim It Down?
Denmark’s status as one of the few countries in Europe with an expanding economy rests in part on the success of…
Why Novo Nordisk Stock Imploded This Week
Novo Nordisk shares dropped after slashing full-year sales guidance, primarily due to weakening sales of its blockbuster GLP-1 drugs, Ozempic…
Stock Movers: Novo Nordisk, IAG, Campari (Podcast)
Source: Bloomberg, 4:00 www.bloomberg.com #Stock #Movers #Novo #Nordisk #IAG #Campari #Podcast
Novo Nordisk Shares Plunge, Drag Down Weight-Loss-Drug ETFs
Shares of Danish pharmaceutical giant Novo Nordisk A/S (NVO) tumbled 22% Tuesday after the company slashed its 2025 outlook and…
Novo CEO’s First Test is Winning Back the US Weight Loss Market
Novo Nordisk’s weight loss drugs Ozempic and Wegovy transformed the firm into a global pharmaceutical giant. But four years after…
Bloomberg Intelligence: Novo Falls on Profit Warning (Podcast)
Source: Bloomberg, 20:51 www.bloomberg.com #Bloomberg #Intelligence #Novo #Falls #Profit #Warning #Podcast